Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03520842. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
ClinicalTrials.gov study NCT02459119. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases
ClinicalTrials.gov study NCT02195011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04696055. IPD Sharing: NO. Countries: 8. Publications: 0.
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov study NCT02168777. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zinc Supplement in Regorafenib Treated mCRC Patient
ClinicalTrials.gov study NCT03898102. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
ClinicalTrials.gov study NCT03099486. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
ClinicalTrials.gov study NCT02053376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Agent Regorafenib in Refractory Advanced Biliary Cancers
ClinicalTrials.gov study NCT02115542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ClinicalTrials.gov study NCT02278783. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03657641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy
ClinicalTrials.gov study NCT01939223. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05942768. IPD Sharing: YES. Countries: 1. Publications: 0.
Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma
ClinicalTrials.gov study NCT02587650. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04117945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Ginseng for Patients on Regorafenib
ClinicalTrials.gov study NCT02581059. IPD Sharing: NO. Countries: 1. Publications: 0.
ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction
ClinicalTrials.gov study NCT06856590. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02383433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib [miRNA-seq]
GEO Series GSE154042. Homo sapiens. 72 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Baseline tumor features and peripheral blood immune dynamics that underlie efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab
GEO Series GSE289583. Homo sapiens. 14 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.